Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
about
Terlipressin versus other vasoactive drugs for hepatorenal syndromeTerlipressin for hepatorenal syndromeInvestigational vasopressin receptor modulators in the pipeline.Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock.Vasopressin: a novel target for the prevention and retardation of kidney disease?Acute kidney injury and hepatorenal syndrome in cirrhosis.Complications of cirrhosis. A 50 years flashback.Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver diseaseSevere ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.Terlipressin-induced hyponatremic seizure in a child.Terlipressin-induced ischemic skin necrosis: a rare associationEffects of a single dose of terlipressin on transcutaneous oxygen pressures.Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.Terlipressin versus other vasoactive drugs for hepatorenal syndrome.A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.Involvement of the microvasculature in the pathogenesis of terlipressin-related myocardial infarction.Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome
P2860
Q24188350-871F262F-E14A-48D8-91A8-D12653D91E4EQ24200336-9B0D0200-35E2-4A83-8235-739499331A86Q37546110-D7CCD19C-D8DB-40B0-9520-D1E57851FD6AQ37593091-E05B407D-275E-44DE-B902-F099D39C612FQ38084471-D443746F-3DE1-45CA-B5EB-EA966CF60F11Q38243669-46DCE87A-CE8C-4146-BA4D-A59A58763567Q38424360-A197D60D-E089-4B45-BAE0-D3E708B7EA07Q38654403-2A6C1966-C44C-4EDB-84FE-9A52383C3727Q41782928-33489502-1DBB-4E96-95D8-A712948FA2E1Q41842297-B188261E-15CB-4A4D-83F4-6E2BC35E5573Q42062333-BF43F2A2-6533-46C2-944E-1281ADFB0EB3Q42113031-B44477AB-A615-43EE-922B-2581200A8454Q43103000-807383DC-AB06-4820-B92F-1B6A49A12775Q47319919-696AEC3B-B84E-49D9-B4F5-33617819487DQ47737114-435CF36A-99E3-4FB9-AA56-58F94AB47F7DQ51501472-056E069C-602E-4AF2-ABC3-871E2FB7B391Q52650451-3848C94D-BAF1-4EF3-99E5-3A23B50F3D0AQ56984335-2C0E85BD-37E3-49B6-9231-1B694D08CACA
P2860
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@ast
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@en
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@nl
type
label
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@ast
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@en
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@nl
prefLabel
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@ast
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@en
Efficacy and safety of terlipr ...... eding or hepatorenal syndrome.
@nl
P1433
P1476
Efficacy and safety of terlipr ...... eeding or hepatorenal syndrome
@en
P2093
Flemming Bendtsen
Tine Borup
P2860
P2888
P304
P356
10.1007/S12325-008-0118-7
P407
P577
2008-11-01T00:00:00Z
P5875
P6179
1018721902